← Eichor
Study identifier: NCT06428045 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

STARLITE for Unresectable High-Grade Gliomas

Condition: High Grade Glioma  ·  Sponsor: University of Miami

PhasePhase 1
Planned participants24
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to determine whether newly diagnosed high-grade glioma(s) that cannot be removed surgically change as a result of the study treatment; and to identify and evaluate the potential side effects (good and bad) of the study treatment in patients with newly diagnosed high-grade glioma(s) that cannot be removed surgically.

This description comes directly from the study's public registry record.

Talk to the study team

Ashish Shah, MD  ·  (305) 243-6946  ·  ashah@med.miami.edu

Macarena De La Fuente, MD  ·  (305) 243-2858  ·  MDelaFuente@med.miami.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of MiamiMiami, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06428045